Financhill
Buy
51

OSK Quote, Financials, Valuation and Earnings

Last price:
$130.74
Seasonality move :
8.13%
Day range:
$129.71 - $131.55
52-week range:
$76.82 - $144.30
Dividend yield:
1.56%
P/E ratio:
12.72x
P/S ratio:
0.82x
P/B ratio:
1.82x
Volume:
139.3K
Avg. volume:
628K
1-year change:
37.7%
Market cap:
$8.3B
Revenue:
$10.7B
EPS (TTM):
$10.26

Earnings Data

Next earnings date for OSK
Jan 29
2026
Most recent earnings per share
$3.04
Missed by $0.06
(Oct 29/2025)
Consensus Estimate
$3.10
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OSK Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/29/2026 Q4 $2.6B -- -- $2.31 --
10/29/2025 Q3 $2.8B $2.7B $3.04 $3.10 -$0.06
08/01/2025 Q2 $2.7B $2.7B $3.16 $2.95 $0.21
04/30/2025 Q1 $2.4B $2.3B $1.72 $2.04 -$0.31
01/30/2025 Q4 $2.4B $2.6B $2.33 $2.18 $0.15
10/30/2024 Q3 $2.7B $2.7B $2.75 $2.91 -$0.16
07/31/2024 Q2 $2.8B $2.8B $2.56 $3.01 -$0.45
04/25/2024 Q1 $2.5B $2.5B $2.71 $2.25 $0.47
01/30/2024 Q4 $2.5B $2.5B $2.28 $2.24 $0.05
10/26/2023 Q3 $2.5B $2.5B $2.79 $2.22 $0.57
08/01/2023 Q2 -- $2.4B $2.67 -- --
04/28/2023 Q1 -- $2.3B $1.34 -- --
01/31/2023 Q4 -- $2.2B $1.14 -- --
10/27/2022 Q3 -- $2.1B $1.02 -- --
07/28/2022 Q2 -- $2.1B $0.49 -- --
04/27/2022 Q1 -- $1.9B -$0.00 -- --
01/26/2022 Q4 -- -- $0.09 $0.43 -$0.34
10/28/2021 Q3 -- $2.1B $1.30 -- --
07/29/2021 Q2 -- $2.2B $3.07 -- --
04/28/2021 Q1 -- $1.9B $1.44 -- --
01/27/2021 Q4 -- $1.6B $1.01 -- --
10/29/2020 Q3 -- $1.8B $1.45 -- --
07/30/2020 Q2 -- $1.6B $1.17 -- --
04/29/2020 Q1 -- $1.8B $1.00 -- --
01/29/2020 Q4 -- $1.7B $1.10 -- --
10/30/2019 Q3 -- $2.2B $2.17 -- --
08/01/2019 Q2 -- $2.4B $2.73 -- --
04/30/2019 Q1 -- $2B $1.82 -- --
01/30/2019 Q4 -- $1.8B $1.51 -- --
11/01/2018 Q3 -- $2.1B $2.05 -- --
07/31/2018 Q2 -- $2.2B $2.05 -- --
04/26/2018 Q1 -- $1.9B $1.47 -- --
01/25/2018 Q4 -- $1.6B $0.74 -- --
10/31/2017 Q3 -- $2B $1.23 -- --
08/02/2017 Q2 -- $2B $1.69 -- --
04/26/2017 Q1 -- $1.6B $0.58 -- --
01/26/2017 Q4 -- $1.2B $0.25 -- --
11/01/2016 Q3 -- $1.8B $0.82 -- --
07/28/2016 Q2 -- $1.7B $1.13 -- --
04/28/2016 Q1 -- $1.5B $0.76 -- --
01/28/2016 Q4 -- $1.3B $0.20 -- --

Oshkosh Corp. Earnings Questions

  • How Much did Oshkosh Corp. Generate in Revenue Last Quarter?

    Oshkosh Corp. reported $2.7B worth of top line sales in its most recent quarter.

  • Did Oshkosh Corp. Beat Earnings Last Quarter?

    Oshkosh Corp. announced earnings per share of $3.04 which represents a miss of analyst forecast a $3.10 per share.

  • Is Oshkosh Corp. Profitable?

    Oshkosh Corp. reported $456.6M that represents $7.07 per share over the last quarter.

  • What is the Analyst Consensus for Oshkosh Corp. EPS Next Year?

    Oshkosh Corp.'s earnings are forecast to grow from $10.35 per share to $11.33 per share next year representing an increase of 5.02%.

  • When is Oshkosh Corp.'s Earnings Date?

    Oshkosh Corp.'s next earnings date is January 29, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock